Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

1110, 2014

Virginia Rotella et al., EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition. Journal of Experimental & Clinical Cancer Research

508, 2014

Claudia Rengucci et al., Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence. Journal of Experimental & Clinical Cancer Research

408, 2014

Caterina Fumagalli et al., Prevalence and Clinicopathologic Correlates of O6-Methylguanine-DNA Methyltransferase Methylation Status in Patients With Triple-Negative Breast Cancer Treated Preoperatively by Alkylating Drugs. Clinical Breast Cancer

107, 2014

Esther Diana Rossi et al., Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience. Cancer Cytopathology

106, 2014

Giovanna De Maglio et al., COMPARISON OF A NEW MULTIPLEXED MULTIGENE APPROACH WITH PYROSEQUENCING IN DIAGNOSTIC MOLECULAR BIOLOGY OF COLORECTAL CANCER (CRC). Annals of Oncology

505, 2014

Anna Crescenzi et al., Immunohistochemistry for BRAF(V600E) Antibody VE1 Performed in Core Needle Biopsy Samples Identifies Mutated Papillary Thyroid Cancers. Hormone and Metabolic Research

505, 2014

Riccardo Giannini et al., KRAS and BRAF genotyping of synchronous colorectal carcinomas. Oncology Letters

1504, 2014

Alessandro Del Gobbo et al., Synchronous pleural and peritoneal malignant mesothelioma: a case report and review of literature. International Journal of Clinical & Experimental Pathology

1404, 2014

Valentina Guarneri et al., Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase IIB Neoadjuvant Study of Letrozole-Lapatinib in Postmenopausal Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, Operable Breast Cancer. Journal of Clinical Oncology

1404, 2014

Daniele Barbaro et al., The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis. Endocrine

104, 2014

Fabio Coppedè et al., Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: Correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism. Epigenetics

104, 2014

Maria Iole Natalicchio et al., Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinoma. Future Oncology

Precedente 323334 Successivo

Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Pubblicazioni

Leader in Italia nella ricerca e nella commercializzazione di kit diagnostici per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici